#1 for women · Top pick
Grade ACoreAge Rx
The most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.
Luna Fit
93/100
Women's metabolic health · Independent · 2026
GLP-1 care that accounts for women's bodies.
PCOS, perimenopause, hormones and labs change what “a good provider” means. We review GLP-1 telehealth through a women's-health lens and rank each on the Luna Fit Score — 9 reviewed, no pay-to-win placement.
Start here
The women's-health angle, in three guides
PCOS01
PCOS & insulin resistance
Why GLP-1 medicines target the metabolic engine of PCOS — and what to ask a provider about tirzepatide, labs and androgens.
Read the guide →Perimenopause02
Perimenopause & menopause
The midlife metabolic shift is real. How GLP-1 care fits alongside the hormonal changes of the menopause transition.
Read the guide →Hormones03
Cycle & hormones
Appetite, thyroid, contraception and the menstrual cycle — the women's-specific questions worth raising before you start.
Read the guide →The ranking · 9 reviewed
Best GLP-1 providers for women
Scored on six women's-health factors: pcos & hormonal suitability · clinical oversight & labs · price transparency · nationwide access · ongoing support · cancellation fairness. Partner = available through our affiliate program; editorial review = no commercial relationship. See our disclosure.
1Best for women
Luna Fit
93/100
CoreAge Rx
PartnerThe most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.
- Semaglutide
- $149/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
- Both compounded semaglutide and tirzepatide on one account — tirzepatide is often preferred where insulin resistance drives PCOS weight
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Available in all 50 states — no coverage gaps if you move or travel
- Not the rock-bottom price — budget shoppers can find cheaper teaser tiers elsewhere
- No FDA-approved brand-name option (compounded only)
- General metabolic program rather than a dedicated hormone/PCOS clinic
2Ranked
Luna Fit
91/100
Eden
PartnerA high-touch, high-disclosure program — the strongest clinical oversight and lab framing on our partner list, which matters when hormones are in play.
- Semaglutide
- $239/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
- Strong clinical oversight and clear clinician/supply-chain disclosure
- Nationwide availability with both molecules
- High verification confidence — useful when you want labs and follow-up, not just a prescription
- Premium pricing versus the cheapest tiers
- Compounded only — no brand-name access
- Not a hormone-specialty clinic; PCOS framing is general
3Ranked
Luna Fit
85/100
AgelessRx
PartnerA longevity-leaning brand whose hormone and healthy-aging catalog speaks directly to the perimenopause transition — plus some of the lower semaglutide pricing.
- Semaglutide
- $139/mo
- Tirzepatide
- Not disclosed
- Coverage
- Not disclosed
- Brand-name
- Yes
- Hormone- and longevity-oriented catalog relevant to the perimenopausal metabolic shift
- Lower-end semaglutide pricing and some brand-name access
- Established brand with a healthy-aging clinical framing
- Tirzepatide pricing not disclosed
- States-served not published
- Not a dedicated PCOS program
4Ranked
Luna Fit
84/100
Invigor Medical
PartnerAn established telehealth pharmacy with a broad metabolic and hormone catalog — handy if you want GLP-1 care inside a wider hormonal-wellness program.
- Semaglutide
- $199/mo
- Tirzepatide
- $339/mo
- Coverage
- Not disclosed
- Brand-name
- Compounded only
- Broad hormone and metabolic catalog beyond GLP-1
- Mid-market pricing on both molecules, both disclosed
- Long-running operator with clinician oversight
- Does not publish an explicit states-served list
- Compounded only
- Catalog breadth over PCOS-specific specialization
5Ranked
Luna Fit
83/100
ShedRx
PartnerA weight-focused program that also offers an oral/sublingual route — a genuine relief for the needle-averse and for anyone easing in gradually.
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Not disclosed
- Brand-name
- Compounded only
- Offers oral/sublingual forms — a real alternative to weekly shots
- Competitive tirzepatide pricing
- Weight-focused program with titration support
- States-served not disclosed
- Compounded only
- Hormonal/PCOS framing is general, not specialized
6Ranked
Luna Fit
87/100
Found
Editorial reviewA coaching-first program with aggressive, identical pricing on both molecules — the behavior-change support can suit the lifestyle side of PCOS well.
- Semaglutide
- $129/mo
- Tirzepatide
- $129/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
- Low, identical pricing on both molecules, nationwide
- Strong behavior-change coaching — useful for the lifestyle levers in PCOS
- Whole-person program rather than prescription-only
- Coaching-subscription model isn't for everyone
- Compounded only
- Editorial review — no commercial relationship with us
7Ranked
Luna Fit
86/100
Ro
Editorial reviewA heavyweight platform with brand-name (Wegovy/Zepbound) access and insurance navigation — powerful if you want an FDA-approved product, but compounded pricing is opaque.
- Semaglutide
- Not disclosed
- Tirzepatide
- Not disclosed
- Coverage
- Multi-state
- Brand-name
- Yes
- Brand-name (Wegovy/Zepbound) access and insurance navigation
- Oral options and a well-funded, polished experience
- Strong clinical infrastructure
- Does not publicly disclose compounded pricing up front
- Premium positioning
- Editorial review — no commercial relationship with us
8Ranked
Luna Fit
85/100
Hims & Hers
Editorial reviewThe Hers side is one of the few mass-market brands built around a women's identity — app-first, nationwide, though its hormonal depth is thin.
- Semaglutide
- $199/mo
- Tirzepatide
- Not disclosed
- Coverage
- All 50 states
- Brand-name
- Compounded only
- Explicit women-focused (Hers) positioning and brand trust
- Nationwide with a slick app experience
- Simple, mass-market onboarding
- Tirzepatide pricing not consistently disclosed
- Limited hormonal/PCOS depth behind the branding
- Editorial review — no commercial relationship with us
9Ranked
Luna Fit
83/100
Henry Meds
Editorial reviewA flat-fee compounded pioneer — a simple, well-known model, but priced at the higher end now with no hormone-specific angle.
- Semaglutide
- $249/mo
- Tirzepatide
- $349/mo
- Coverage
- Multi-state
- Brand-name
- Compounded only
- Simple flat-fee model with both molecules
- Well-established, widely recognized brand
- Clear, predictable billing
- Higher pricing than many newer entrants
- Compounded only, no hormone-specific framing
- Editorial review — no commercial relationship with us
Pricing, states and verification facts reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on the provider's site. Not medical advice.
Before you start
Is GLP-1 care worth a conversation?
A quick, private self-check framed for women's metabolic health. Nothing is saved or sent — it simply helps you decide whether to raise GLP-1 care with a clinician.
A gentle self-check
Is GLP-1 care worth a conversation for you?
Reflective only — not a diagnosis. Nothing is saved or sent.
0 of 6 selected. Tick the ones that sound like you — there are no wrong answers.
A women's-health rubric
Six factors weighted for women — PCOS and hormonal suitability, labs and oversight — applied the same way to every provider, partner or not.
Honest about limits
Most telehealth brands aren't hormone clinics. We say where the PCOS or perimenopause framing is general, and rank accordingly.
No pay-to-win
Affiliate status is disclosed on every card and never buys a higher Luna Fit Score.